"Exploring the Risks: Chronic Microdosing of Psychedelics and Valvular Heart Disease"
A scientific review published in the Journal of Psychopharmacology has raised concerns about the potential link between chronic microdosing of psychedelics and valvular heart disease (VHD). The review examined commonly used psychedelics, including LSD, psilocin, mescaline, DMT, and MDMA, and their interaction with the 5-HT2B receptor, which has been associated with the development of VHD. While there is a lack of concrete scientific evidence to confirm or refute the existence of a direct link, the researchers concluded that VHD is a potential risk with chronic psychedelic microdosing and further studies are necessary to better define this risk.
